| Literature DB >> 27167081 |
Shayan Amiri1, Sakineh Alijanpour2, Fatemeh Tirgar3, Arya Haj-Mirzaian4, Hossein Amini-Khoei4, Maryam Rahimi-Balaei5, Mojgan Rastegar6, Marzieh Ghaderi3, Mahmoud Ghazi-Khansari4, Mohammad-Reza Zarrindast7.
Abstract
Amphetamine withdrawal (AW) is accompanied by diminished pleasure and depression which plays a key role in drug relapse and addictive behaviors. There is no efficient treatment for AW-induced depression and underpinning mechanisms were not well determined. Considering both transient receptor potential cation channel, subfamily V, member 1 (TRPV1) and N-Methyl-d-aspartate (NMDA) receptors contribute to pathophysiology of mood and addictive disorders, in this study, we investigated the role of TRPV1 and NMDA receptors in mediating depressive-like behaviors following AW in male mice. Results revealed that administration of capsaicin, TRPV1 agonist, (100μg/mouse, i.c.v.) and MK-801, NMDA receptor antagonist (0.005mg/kg, i.p.) reversed AW-induced depressive-like behaviors in forced swimming test (FST) and splash test with no effect on animals' locomotion. Co-administration of sub-effective doses of MK-801 (0.001mg/kg, i.p.) and capsaicin (10μg/mouse, i.c.v) exerted antidepressant-like effects in behavioral tests. Capsazepine, TRPV1 antagonist, (100μg/mouse, i.c.v) and NMDA, NMDA receptor agonist (7.5mg/kg, i.p.) abolished the effects of capsaicin and MK-801, respectively. None of aforementioned treatments had any effect on behavior of control animals. Collectively, our findings showed that activation of TRPV1 and blockade of NMDA receptors produced antidepressant-like effects in male mice following AW, and these receptors are involved in AW-induced depressive-like behaviors. Further, we found that rapid antidepressant-like effects of capsaicin in FST and splash test are partly mediated by NMDA receptors.Entities:
Keywords: FST; NMDA receptors; TRPV1; amphetamine withdrawal; depression; splash test
Mesh:
Substances:
Year: 2016 PMID: 27167081 DOI: 10.1016/j.neuroscience.2016.05.003
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590